We are a Cancer Research UK (CRUK) supported team of expert doctors & scientists, from Oxford University’s oncology, immunology, antigen discovery, vaccinology & biomanufacturing departments... We're pushing the boundaries of science & medicine, to identify hidden tumour targets, enabling us to create high efficiency vaccines. We are developing these to be affordable
Location: United Kingdom
Employees: 11-50
Total raised: $16.06M
Investors 2
| Date | Name | Website |
| 09.02.2024 | Martlet | martletcap... |
| 04.07.2023 | Manta Ray ... | mantaray.v... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.05.2024 | Seed | $16.06M | - |
Mentions in press and media 6
| Date | Title | Description |
| 02.05.2024 | Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers | Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1 OXFORD, England, May 2, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen ... |
| 01.05.2024 | Infinitopes Revolutionizing Cancer Treatment with £12.8M Seed Financing | Infinitopes Precision Immunomics, a UK-based cancer biotech company, secures £12.8M in seed funding to accelerate the development of precision cancer vaccines targeting multiple solid tumor indications. Led by CEO Jonathan Kwok, Infinitopes... |
| 01.05.2024 | Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers | Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1 OXFORD, England, May 1, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen ... |
| 01.05.2024 | Infinitopes Raises £12.8M in Seed Financing | Infinitopes Precision Immunomics, an Oxford, UK-based integrated cancer biotech company, raised £12.8M in Seed funding. The round was led by Octopus Ventures with participation from Cancer Research Horizons, Cancer Research Institute, CRIS ... |
| - | Infinitopes | “Empowering the Future” |
| - | Infinitopes: Cancer Biotechnology Company Raises £12.8 Million | Infinitopes Precision Immunomics, an integrated cancer biotech integrating sophisticated platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, announced the completion of a... |